SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cronos is an institutional-grade, high-performance, EVM-compatible Layer-1 blockchain built on the Cosmos SDK and integrated with the Inter-Blockchain Communication (IBC) protocol, designed as the backbone for open, compliant, and AI-accessible tokenized markets. It supports up to 60,000 transactions per second (TPS), 500ms block times, instant finality, and sub-$0.01 fees via Proof of Authority consensus.

Crypto.com Coin

Crypto.com Coin is trending as investors debate ongoing token dilution and mixed sentiments regarding the exchange's future growth initiatives. Community members are simultaneously buzzing over the native meme coin $MERY.X, highlighting its decentralized structure and perceived security benefits as a key focal point for current market activity.

Bakkt, Inc. is building the backbone of next-generation financial infrastructure. The company provides solutions that enable institutional participation in the digital asset economy, spanning Bitcoin, tokenization, stablecoin payments, and AI-driven finance. Bakkt was founded in 2018 and is headquartered in New York, NY.

Bakkt Inc. - Ordinary Shares - Class A

Bakkt Inc. (BKKT) is experiencing significant downward pressure as investors react to a challenging earnings report and ongoing uncertainty regarding the company's business model transition. While some in the community remain focused on the potential of the new AI-powered infrastructure and institutional partnerships, sentiment is broadly pessimistic, with active discussions dominated by frustration over poor price performance, skepticism toward management's long-term strategy, and concerns over potential further dilution or delisting risks.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is trending as investors digest a strong quarterly earnings report featuring revenue that exceeded expectations and raised full-year guidance, even as the stock faces ongoing pressure from heavy short interest. Community discussion is sharply divided between long-term bulls highlighting institutional support and progress in FAA certification, and skeptics focused on cash burn and the company's long-term path to commercial profitability.

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Branded and ImprimisRx. The Branded segment includes activities of the company’s FDA approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain branded products. The ImprimisRx segment represents activities in the company’s ophthalmology-focused pharmaceutical compounding business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Harrow Inc

Harrow Health Inc

Harrow Health is trending as investors weigh significant long-term growth potential in its ophthalmology portfolio against recent volatility caused by management guidance adjustments and institutional selling. While community sentiment remains largely bullish, focusing on the rapid adoption of Vevye and upcoming biosimilar launches, investors are actively debating the timing of revenue execution and the company's ability to consistently meet future financial targets.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

Johnson & Johnson is trending due to strong institutional interest and upward momentum, supported by a positive Elliott Wave analysis and recent analyst upgrades that highlight its oncology pipeline as a primary driver for future growth. The company is actively being discussed as a potential major player in oncology M&A, with investors focusing on its strategic acquisition of Firefly Bio and its goal of becoming the world's leading oncology company by 2030.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Dallas, TX.

United States Antimony Corp.

United States Antimony Corp. is seeing a surge in community engagement as investors track the CEO's involvement in high-level government roundtables on critical minerals and the company's role as a sole domestic supplier for defense applications. While community discourse remains heavily focused on potential supply chain catalysts, institutional activity, and the upcoming earnings report, sentiment is polarized between long-term holders eyeing strategic supply shortages and those concerned by recent volatility.

Atlassian Corp. is a holding company, which engages in providing team collaboration and productivity software. Its products include Jira Software, Confluence, Jira Service Management, and Loom. The company was founded by Michael Cannon-Brookes and Scott Farquhar in October 2002 and is headquartered in San Francisco, CA.

Atlassian Corporation - Ordinary Shares - Class A

Atlassian Corporation Plc

Atlassian is experiencing significant momentum after a strong earnings report and a cloud-growth outlook that defied sector-wide pessimism. The community is actively discussing a mix of bullish sentiment driven by AI-powered workflow integration and caution from traders wary of potential volatility following the stock's sharp, euphoric rally.

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Senseonics Holdings Inc

Senseonics is attracting intense community debate as the stock faces volatility following a recent share offering priced at $5, with investors divided between those viewing the price dip as a strategic entry point and those expressing frustration over ongoing dilution and management's execution. The conversation is largely centered on the company's ability to scale the Eversense 365 commercial adoption and reach profitability, with participants closely monitoring upcoming earnings and pipeline developments for signs of long-term viability.

VanEck ETF Trust - VanEck Gold Miners ETF

VanEck Gold Miners ETF

GDX is experiencing significant volatility and trading volume as investors react to mixed economic signals, including elevated inflation data and ongoing central bank gold accumulation. The community remains divided, with many debating whether the current pullback represents a strategic bottoming phase or a deeper correction driven by interest rate uncertainties and broader market instability.

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Vertex Pharmaceuticals, Inc.

Vertex Pharmaceuticals is currently trending due to positive clinical results for its kidney disease drug povetacicept and ongoing investor discussions regarding the company's aggressive expansion beyond its core cystic fibrosis business. The community is actively debating the potential for M&A activity, particularly a possible acquisition of CRISPR Therapeutics, and analyzing the long-term impact of its diversified pipeline on future growth.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
